Glaxosmithkline Llc Pac (Gsk Pac) YEAR-END Filings

Cycle Date Filed End Date Amendment Receipts Spending Cash
2024 Jan. 23 Dec. 31, 2023 $23,229.00 $11,043.61 $26,169.16
2022 Jan. 24, 2023 Dec. 31, 2022 $22,962.23 $13,690.83 $42,297.02
2022 March 17, 2022 Dec. 31, 2021 Compare to original $24,576.07 $16,683.69 $118,308.78
2020 Jan. 13, 2021 Dec. 31, 2020 $24,596.21 $39,526.01 $90,242.71
2020 Jan. 13, 2020 Dec. 31, 2019 $24,980.19 $44,520.83 $166,398.72
2018 Jan. 30, 2019 Dec. 31, 2018 $30,621.56 $125.07 $122,719.67
2018 Jan. 29, 2018 Dec. 31, 2017 $32,711.69 $24,537.16 $88,460.86
2016 Jan. 27, 2017 Dec. 31, 2016 $30,354.19 $7,098.75 $83,793.57
2016 Jan. 29, 2016 Dec. 31, 2015 $30,707.78 $39,758.84 $128,174.40
2016 Jan. 30, 2015 Dec. 31, 2014 $40,262.72 $13,153.40 $136,641.09
2014 Jan. 22, 2014 Dec. 31, 2013 $42,142.98 $19,201.63 $121,675.58
2012 Jan. 30, 2013 Dec. 31, 2012 $42,685.64 $28,594.26 $72,107.65
2012 Jan. 30, 2012 Dec. 31, 2011 $42,864.17 $63,183.74 $71,434.77
2010 Jan. 28, 2011 Dec. 31, 2010 $72,842.20 $37,340.20 $105,298.00
2010 Jan. 25, 2010 Dec. 31, 2009 $63,367.57 $114,277.53 $139,189.11
2008 Sept. 18, 2009 Dec. 31, 2008 Compare to original $108,990.00 $12,864.00 $109,673.00
2008 Sept. 18, 2009 Dec. 31, 2007 Compare to original $76,627.50 $154,850.00 $139,142.00
2006 Jan. 29, 2007 Dec. 31, 2006 $118,027.96 $20,350.00 $152,450.38
2006 Jan. 20, 2006 Dec. 31, 2005 $122,396.00 $107,116.00 $465,554.00
2004 Jan. 28, 2005 Dec. 31, 2004 $125,019.00 $18,035.00 $234,031.00
2004 Feb. 19, 2004 Dec. 31, 2003 Compare to original $78,002.70 $67,016.80 $283,793.00
2002 Jan. 16, 2003 Dec. 31, 2002 View View
2002 March 19, 2002 Dec. 31, 2001 View View
2000 Jan. 18, 2001 Dec. 31, 2000 View View